Table of Content

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines


2. EXECUTIVE SUMMARY


3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Reconstitution Systems
3.2.1. Key Considerations in Drug Reconstitution

3.3. Lyophilization of Pharmaceuticals
3.3.1. Need for Reconstitution Systems
3.3.2. Dual Chamber / Multi Chamber Systems
3.3.3. One Step Reconstitution Systems
3.3.4. Conventional Reconstitution Systems

3.4. Advantages of Drug Reconstitution Systems
3.4.1. Benefits to Pharmaceutical Players
3.4.2. Benefits to Patients
3.5. Concluding Remarks

4. MARKET LANDSCAPE: NOVEL DRUG RECONSTITUTION SYSTEMS
4.1. Chapter Overview
4.2. Novel Drug Reconstitution Systems: Product Pipeline
4.2.1. Analysis by Type of Device
4.2.2. Analysis by Type of Chamber
4.2.3. Analysis by Type of Device and Type of Chamber
4.2.4. Analysis by Physical State of Drug
4.2.5. Analysis by Container Fabrication Material
4.2.6. Analysis by Device Usability
4.2.7. Analysis by Container Fabrication Material and Device Usability
4.2.8. Analysis by Volume of Container
4.3. Novel Drug Reconstitution Systems: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Region of Headquarters
4.3.4. Analysis by Company Size and Region of Headquarters
4.3.5. Analysis by Location of Headquarters
4.3.6. Leading Players: Analysis by Number of Novel Drug Reconstitution Systems Manufactured

5. MARKET LANDSCAPE: OTHER RECONSTITUTION SYSTEMS
5.1. Chapter Overview
5.2. One Step Reconstitution Systems: Product Pipeline
5.2.1. Analysis by Type of Primary Container
5.2.2. Analysis by Volume of Primary Container
5.2.3. Analysis by Physical State of Drug
5.2.4. Analysis by Device Usability
5.2.5. Analysis by Type of Primary Container and Physical State of Drug
5.3. One Step Reconstitution Systems: Developer Landscape
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Leading Players: Analysis by Number of One Step Reconstitution Systems Manufactured
5.4. Conventional Reconstitution Devices: Development Pipeline
5.4.1. Analysis by Status of Development
5.4.2. Analysis by Type of Device
5.4.3. Analysis by Type of Primary Container
5.4.4. Analysis by Physical State of Drug
5.4.5. Analysis by Type of Primary Container and Physical State of Drug
5.5. Conventional Reconstitution Devices: Developer Landscape
5.5.1. Analysis by Year of Establishment
5.5.2. Analysis by Company Size
5.5.3. Analysis by Location of Headquarters
5.5.4. Analysis by Region of Headquarters
5.5.5. Leading Players: Analysis by Number of Conventional Reconstitution Devices Manufactured

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Key Players based in North America
6.2.1. Baxter
6.2.1.1. Company Overview
6.2.1.2. Financial Information
6.2.1.3. Product Portfolio
6.2.1.4. Recent Developments and Future Outlook
6.2.2. ICU Medical
6.2.2.1. Company Overview
6.2.2.2. Financial Information
6.2.2.3. Product Portfolio
6.2.2.4. Recent Developments and Future Outlook
6.3. Key Players based in Europe
6.3.1. B. Braun
6.3.1.1. Company Overview
6.3.1.2. Financial Information
6.3.1.3. Product Portfolio
6.3.1.4. Recent Developments and Future Outlook
6.3.2. Vetter Pharma
6.3.2.1. Company Overview
6.3.2.2. Product Portfolio
6.3.2.3. Recent Developments and Future Outlook
6.4. Key Players based in Asia-Pacific
6.4.1. Nipro
6.4.1.1. Company Overview
6.4.1.2. Financial Information
6.4.1.3. Product Portfolio
6.4.1.4. Recent Developments and Future Outlook
6.4.2. SCHOTT-KAISHA
6.4.2.1. Company Overview
6.4.2.2. Product Portfolio
6.4.2.3. Recent Developments and Future Outlook

7. PACKAGING TREND ANALYSIS FOR APPROVED DRUGS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. List of Approved Drugs (2014-H1 2021)
7.3.1. Analysis by Type of Molecule and Approval Year
7.3.2. Analysis by Type of Molecule
7.3.3. Analysis by Type of Biologic
7.3.4. Analysis by Type of Molecule and Holding Temperature
7.3.5. Analysis by Type of Biologic and Dosage Form
7.4. Primary Packaging Containers for Approved Drugs
7.4.1. Analysis by Type of Primary Packaging Container
7.4.2. Analysis by Type of Primary Packaging Container and Approval Year
7.4.3. Analysis by Type of Primary Packaging Container and Type of Molecule
7.4.4. Analysis by Type of Primary Packaging Container and Holding Temperature Range
7.4.5. Analysis by Type of Primary Packaging Container and Dosage Form
7.4.6. Analysis by Type of Primary Packaging Container and Route of Administration
7.4.7. Most Popular Materials Used for Containers: Analysis by Number of Drugs
7.5. Primary Packaging Closures for Approved Drugs
7.5.1. Analysis by Type of Primary Packaging Closure
7.5.2. Analysis by Type of Primary Packaging Closure and Approval Year
7.5.3. Analysis by Type of Primary Packaging Closure and Type of Molecule
7.5.4. Analysis by Type of Primary Packaging Closure and Holding Temperature Range
7.5.5. Analysis by Type of Primary Packaging Closure and Dosage Form
7.5.6. Analysis by Type of Primary Packaging Closure and Route of Administration
7.5.7. Most Popular Materials Used for Closures: Analysis by Number of Drugs
7.6. Packaging Trend Analysis for Approved Drugs: Developer Landscape
7.6.1. Analysis by Year of Establishment
7.6.2. Analysis by Company Size
7.6.3. Analysis by Location of Headquarters
7.6.4. Analysis by Type of Molecules and Company Size
7.6.5. Analysis by Type of Molecule and Geographical Location of Developers
7.6.6. Analysis by Type of Biologics and Geographical Location of Developers
7.6.7. Most Active Players: Analysis by Type of Molecule
7.6.8. Most Active Players: Analysis by Number of Biologics Developed
7.6.9. Most Active Players: Analysis by Type of Biologic
7.6.10. Most Active Players: Analysis by Number of Small Molecules Developed
7.7. Concluding Remarks

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Novel Drug Reconstitution Systems: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Application Year
8.3.3. Analysis by Geographical Location
8.3.4. Analysis by CPC Symbols
8.3.5. Word Cloud: Emerging Focus Areas
8.3.6. Analysis by Type of Organization
8.3.7. Leading Players: Analysis by Number of Patents
8.4. Novel Drug Reconstitution Systems: Patent Benchmarking Analysis
8.4.1. Analysis by Patent Characteristics
8.5. Novel Drug Reconstitution Systems: Patent Valuation Analysis
8.6. Leading Patents by Number of Citations
9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Chapter Overview
9.2. Assumptions / Key Parameters
9.3. Methodology
9.4. Company Competitiveness Analysis: Novel Drug Reconstitution System Manufacturers in North America
9.5. Company Competitiveness Analysis: Novel Drug Reconstitution System Manufacturers in Europe
9.6. Company Competitiveness Analysis: Novel Drug Reconstitution System Manufacturers in Asia-Pacific and Rest of the World
10. GLOBAL EVENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Events related to Novel Drug Reconstitution Systems
10.3.1. Analysis by Year of Event
10.3.2. Analysis by Event Platform
10.3.3. Analysis by Type of Event
10.3.4. Analysis by Geography
10.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Area
10.3.6. Most Active Event Organizers
10.3.7. Most Active Participants: Analysis by Number of Events
10.3.8. Analysis by Seniority Level of Participants
10.3.9. Most Active Speakers: Analysis by Number of Events
10.3.10. Geographical Mapping of Upcoming Events
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Novel Drug Reconstitution Systems: SWOT Analysis
11.2.1. Comparison of SWOT Factors
12. DEMAND ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Global Demand for Dual Chamber Prefilled Syringes, 2021-2035
12.3.1. Analysis by Physical State of Drug
12.3.1.1. Global Demand of Dual Chamber Prefilled Syringes for Liquid / Powder Drugs, 2021-2035
12.3.1.2. Global Demand of Dual Chamber Prefilled Syringes for Liquid / Liquid Drugs, 2021-2035
12.3.2. Analysis by Type of Fabrication Material
12.3.2.1. Global Demand for Glass Dual Chamber Prefilled Syringes, 2021-2035
12.3.2.2. Global Demand for Plastic Dual Chamber Prefilled Syringes, 2021-2035
12.3.3. Analysis by Volume
12.3.3.1. Global Demand for <1 mL Dual Chamber Prefilled Syringes, 2021-2035
12.3.3.2. Global Demand for 1-2.5 mL Dual Chamber Prefilled Syringes, 2021-2035
12.3.3.3. Global Demand for 2.5-5 mL Dual Chamber Prefilled Syringes, 2021-2035
12.3.3.4. Global Demand for >5 mL Dual Chamber Prefilled Syringes, 2021-2035
12.3.4. Analysis by Geography
12.3.4.1. Global Demand of Dual Chamber Prefilled Syringes in North America, 2021-2035
12.3.4.2. Global Demand of Dual Chamber Prefilled Syringes in Europe, 2021-2035
12.3.4.3. Global Demand of Dual Chamber Prefilled Syringes in Asia-Pacific, 2021-2035
12.3.4.4. Global Demand of Dual Chamber Prefilled Syringes in Latin America, 2021-2035
12.3.4.5. Global Demand of Dual Chamber Prefilled Syringes in Middle East and Africa, 2021-2035
12.4. Global Demand for Dual Chamber Cartridges, 2021-2035
12.4.1. Analysis by Physical State of Drug
12.4.1.1. Global Demand of Dual Chamber Cartridges for Liquid / Powder Drugs, 2021-2035
12.4.1.2. Global Demand of Dual Chamber Cartridges for Liquid / Liquid Drugs, 2021-2035
12.4.2. Analysis by Type of Fabrication Material
12.4.2.1. Global Demand for Glass Dual Chamber Cartridges, 2021-2035
12.4.2.2. Global Demand for Plastic Dual Chamber Cartridges, 2021-2035
12.4.3. Analysis by Volume
12.4.3.1. Global Demand for <1 mL Dual Chamber Cartridges, 2021-2035
12.4.3.2. Global Demand for 1-2.5 mL Dual Chamber Cartridges, 2021-2035
12.4.3.3. Global Demand for 2.5-5 mL Dual Chamber Cartridges, 2021-2035
12.4.3.4. Global Demand for >5 mL Dual Chamber Cartridges, 2021-2035
12.4.4. Analysis by Geography
12.4.4.1. Global Demand of Dual Chamber Cartridges in North America, 2021-2035
12.4.4.2. Global Demand of Dual Chamber Cartridges in Europe, 2021-2035
12.4.4.3. Global Demand of Dual Chamber Cartridges in Asia-Pacific, 2021-2035
12.4.4.4. Global Demand of Dual Chamber Cartridges in Latin America, 2021-2035
12.4.4.5. Global Demand of Dual Chamber Cartridges in Middle East and Africa, 2021-2035
12.4.4.6. Global Demand of Dual Chamber Cartridges in Rest of the World, 2021-2035
12.5. Global Demand for Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.1. Analysis by Physical State of Drug
12.5.1.1. Global Demand of Dual / Multi Chamber Infusion Bags for Liquid Mixture, 2021-2035
12.5.1.2. Global Demand of Dual / Multi Chamber Infusion Bags for Frozen Mixture, 2021-2035
12.5.2. Analysis by Type of Plastic
12.5.2.1. Global Demand of Ethylene Vinyl Acetate made Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.2.2. Global Demand of Polypropylene made Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.2.3. Global Demand of Polyvinyl Chloride made Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.2.4. Global Demand of Other Plastic made Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.3. Analysis by Volume
12.5.3.1. Global Demand for 0-250 mL Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.3.2. Global Demand for 250-500 mL Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.3.3. Global Demand for 500-1,000 mL Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.3.4. Global Demand for >1,000 mL Dual / Multi Chamber Infusion Bags, 2021-2035
12.5.4. Analysis by Geography
12.5.4.1. Global Demand of Dual / Multi Chamber Infusion Bags in North America, 2021-2035
12.5.4.2. Global Demand of Dual / Multi Chamber Infusion Bags in Europe, 2021-2035
12.5.4.3. Global Demand of Dual / Multi Chamber Infusion Bags in Asia-Pacific, 2021-2035
12.5.4.4. Global Demand of Dual / Multi Chamber Infusion Bags in Latin America, 2021-2035
12.5.4.5. Global Demand of Dual / Multi Chamber Infusion Bags in Middle East and Africa, 2021-2035
12.6. Concluding Remarks

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Methodology and Key Assumptions
13.3. Global Dual Chamber Prefilled Syringes Market, 2021-2035
13.3.1. Dual Chamber Prefilled Syringes Market, 2021-2035: Distribution by Physical State of Drug
13.3.1.1. Dual Chamber Prefilled Syringes Market for Liquid / Powder Drugs, 2021-2035
13.3.1.2. Dual Chamber Prefilled Syringes Market for Liquid / Liquid Drugs, 2021-2035
13.3.2. Dual Chamber Prefilled Syringes Market, 2021-2035: Distribution by Type of Fabrication Material Used
13.3.2.1. Glass Dual Chamber Prefilled Syringes Market, 2021-2035
13.3.2.2. Plastic Dual Chamber Prefilled Syringes Market, 2021-2035
13.3.3. Dual Chamber Prefilled Syringes Market, 2021-2035: Distribution by Volume
13.3.3.1. Dual Chamber Prefilled Syringes Market for <1 mL Syringes, 2021-2035
13.3.3.2. Dual Chamber Prefilled Syringes Market for 1-2.5 mL Syringes, 2021-2035
13.3.3.3. Dual Chamber Prefilled Syringes Market for 2.5-5 mL Syringes, 2021-2035
13.3.3.4. Dual Chamber Prefilled Syringes Market for >5 mL Syringes, 2021-2035
13.3.4. Dual Chamber Prefilled Syringes Market, 2021-2035: Distribution by Geography
13.3.4.1. Dual Chamber Prefilled Syringes Market in North America, 2021-2035
13.3.4.2. Dual Chamber Prefilled Syringes Market in Europe, 2021-2035
13.3.4.3. Dual Chamber Prefilled Syringes Market in Asia-Pacific, 2021-2035
13.3.4.4. Dual Chamber Prefilled Syringes Market in Latin America, 2021-2035
13.3.4.5. Dual Chamber Prefilled Syringes Market in Middle East and Africa, 2021-2035
13.4. Global Dual Chamber Cartridges Market, 2021-2035
13.4.1. Dual Chamber Cartridges Market, 2021-2035: Distribution by Physical State of Drug
13.4.1.1. Dual Chamber Cartridges Market for Liquid / Powder Drugs, 2021-2035
13.4.1.2. Dual Chamber Cartridges Market for Liquid / Liquid Drugs, 2021-2035
13.4.2. Dual Chamber Cartridges Market, 2021-2035: Distribution by Type of Fabrication Material Used
13.4.2.1. Glass Dual Chamber Cartridges Market, 2021-2035
13.4.2.2. Plastic Dual Chamber Cartridges Market, 2021-2035
13.4.3. Dual Chamber Cartridges Market, 2021-2035: Distribution by Volume
13.4.3.1. Dual Chamber Cartridges Market for <1 mL Cartridges, 2021-2035
13.4.3.2. Dual Chamber Cartridges Market for 1-2.5 mL Cartridges, 2021-2035
13.4.3.3. Dual Chamber Cartridges Market for 2.5-5 mL Cartridges, 2021-2035
13.4.3.4. Dual Chamber Cartridges Market for >5 mL Cartridges, 2021-2035
13.4.4. Dual Chamber Cartridges Market, 2021-2035: Distribution by Geography
13.4.4.1. Dual Chamber Cartridges Market in North America, 2021-2035
13.4.4.2. Dual Chamber Cartridges Market in Europe, 2021-2035
13.4.4.3. Dual Chamber Cartridges Market in Asia-Pacific, 2021-2035
13.4.4.4. Dual Chamber Cartridges Market in Latin America, 2021-2035
13.4.4.5. Dual Chamber Cartridges Market in Middle East and Africa, 2021-2035
13.4.4.6. Dual Chamber Cartridges Market in Rest of the World, 2021-2035
13.5. Global Dual / Multi Chamber Infusion Bags Market, 2021-2035
13.5.1. Dual / Multi Chamber Infusion Bags Market, 2021-2035: Distribution by Physical State of Drug
13.5.1.1. Dual / Multi Chamber Infusion Bags Market for Liquid Mixture, 2021-2035
13.5.1.2. Dual / Multi Chamber Infusion Bags Market for Frozen Mixture, 2021-2035
13.5.2. Dual / Multi Chamber Infusion Bags Market, 2021-2035: Distribution by Type of Plastic
13.5.2.1. Dual / Multi Chamber Infusion Bags Market for Ethylene Vinyl Acetate, 2021-2035
13.5.2.2. Dual / Multi Chamber Infusion Bags Market for Polypropylene, 2021-2035
13.5.2.3. Dual / Multi Chamber Infusion Bags Market for Polyvinyl Chloride, 2021-2035
13.5.2.4. Dual / Multi Chamber Infusion Bags Market for Other Plastic Materials, 2021-2035
13.5.3. Dual / Multi Chamber Infusion Bags Market, 2021-2035: Distribution by Volume
13.5.3.1. Dual / Multi Chamber Infusion Bags Market for 0-250 mL Infusion Bags, 2021-2035
13.5.3.2. Dual / Multi Chamber Infusion Bags Market for 250-500 mL Infusion Bags, 2021-2035
13.5.3.3. Dual / Multi Chamber Infusion Bags Market for 500-1,000 mL Infusion Bags, 2021-2035
13.5.3.4. Dual / Multi Chamber Infusion Bags Market for >1,000 mL Infusion Bags, 2021-2035
13.5.4. Dual / Multi Chamber Infusion Bags Market, 2021-2035: Distribution by Geography
13.5.4.1. Dual / Multi Chamber Infusion Bags Market in North America, 2021-2035
13.5.4.2. Dual / Multi Chamber Infusion Bags Market in Europe, 2021-2035
13.5.4.3. Dual / Multi Chamber Infusion Bags Market in Asia-Pacific, 2021-2035
13.5.4.4. Dual / Multi Chamber Infusion Bags Market in Latin America, 2021-2035
13.5.4.5. Dual / Multi Chamber Infusion Bags Market in Middle East and Africa, 2021-2035

14. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING
14.1. Chapter Overview
14.2. Preference for Self-Medication of Drugs using Modern Drug Delivery Devices
14.3. Development of Innovative Packaging Containers
14.4. Growing Demand for Personalized Therapies
14.5. Integrating Dual Chamber Systems with Other Platforms
14.6. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
14.7. Concluding Remarks

15. CONCLUDING REMARKS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS